| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.1M | — | +58.2% |
| Cost of Revenue | $3.7M | — | +44.6% |
| Gross Profit | $12.4M | — | +62.7% |
| R&D Expense | $5.2M | — | +64.4% |
| SG&A Expense | $6.2M | — | +79.6% |
| Operating Income | -$9.3M | — | -62.2% |
| Interest Expense | $311K | — | -12.9% |
| Income Tax | $0 | — | — |
| Net Income | -$8.7M | — | -51.8% |
| EPS (Basic) | -$0.32 | — | +78.2% |
| EPS (Diluted) | -$0.32 | — | +78.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $73.0M | -14.9% | +68.1% |
| Short-term Investments | $24.0M | +0.0% | — |
| Accounts Receivable | $12.3M | +8.0% | — |
| Inventory | $2.1M | +11.8% | — |
| Current Assets | $115.4M | -8.9% | — |
| Total Assets | $118.8M | -8.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.0M | — | -59.5% |
| Capital Expenditures | $79K | — | -4.8% |
| Investing Cash Flow | -$206K | — | +13.4% |
| Financing Cash Flow | $436K | — | -96.3% |
| Free Cash Flow | -$13.1M | — | -58.8% |
| — |
| Current Liabilities | $9.7M | -32.0% | — |
| Long-term Debt | $15.4M | +0.1% | — |
| Total Liabilities | $26.5M | -15.1% | — |
| Stockholders' Equity | $92.2M | -6.7% | +220.4% |